Sign in
Enrolling by invitationNo phase

Arm and leg cycling with stimulation for people with spinal cord injury

Tests combined arm and leg cycling in adults with incomplete spinal cord injury.

Key facts

Who runs it
Shirley Ryan AbilityLab
Where
Chicago, United StatesSee the site
Trial code
Registry title
Arm and Leg Cycling for Accelerated SCI Recovery
Status
Enrolling by invitation
People taking part
40 people, planned
Started
Dec 2025
Expected to end
Sept 2032
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • A&L cycling
  • Body weight supported treadmill training (BWSTT)
Record updated
23 May 2025

Who can take part

The trial is looking for adults with an incomplete spinal cord injury at T11 or above who can walk on their own but slowly. It compares arm and leg cycling with electrical stimulation to treadmill training with body weight support.

Age
18 to 75 years
Sex
All sexes
Disease stage
Traumatic or non-traumatic spinal cord injury at T11 or above (upper motor neuron injury). Incomplete paraplegia or tetraplegia, AIS C or D. At least 1 year since the injury. Able to walk on your own at least 10 meters (30 feet), with usual walking aids or braces. Walking speed under 0.8 m/s (2.62 ft/s), or as the researchers decide. Arm strength in both arms to cycle at least 15 minutes without help, or as the researchers decide.
Earlier treatment
No other surgery, major medical treatment or therapy during the study, ongoing or planned.
Main reasons for not taking part
  • Injury at T12 or below, complete injury (AIS A) or AIS B injury
  • Progressive nerve disease or another serious disease that would stop full participation
  • Weight over 160 kg (352 lbs)
  • Epilepsy or seizures, metal or implants in the head, pacemaker or neurostimulator, depression or antidepressant or antipsychotic medicines
  • Active blood clot, leg infection, wounds at electrode sites, cancer, pregnancy, or being a prisoner
Show the full registry criteria (20)Hide the full registry criteria

Who can take part

  • Traumatic or non-traumatic SCI T11 and above (upper motorneuron lesion)
  • Incomplete paraplegia or tetraplegia (Classified as AIS C or D)
  • Age range 18-75 years old, inclusive
  • At least 1 year post- injury
  • Independent ambulator (with normal assistive devices or bracing) for at least 10 meters (30 feet)
  • Walking speed <0.8 m/s (2.62 ft/s) (or per researcher discretion)
  • Bilateral arm strength to arm cycle at least 15 minutes without assistance (or per researcher discretion)
  • No concurrent or planned surgeries, significant medical treatments, or therapy during the study period
  • Able to understand and speak English

Who cannot take part

  • TMS contraindications; Epilepsy, seizure disorder, or any other type of seizure history; Medications that increase the risk of seizures; Metal or metal fragments in the head (plates, screws, etc.); Surgical clips in the head or previous neurosurgery; Implants in the head (ex: cochlear implants); Non-prescribed drug or marijuana use; Depression, antidepressant medications, or antipsychotic medications
  • Presence of progressive neurologic disease
  • Significant other disease (ex: cardiological or heart disease, renal, hepatic, malignant tumors, mental or psychiatric disorders) that would prevent participants from fullym engaging in study procedures
  • FES and tSCS contraindications; Active Deep Vein Thrombosis (blood clot); Active infection in the legs; Open wounds, rashes, or infection at the electrode sites; Cancer or recently radiated tissue; Cardiac pacemakers or neurostimulators; Hypersensitivity to or inability to tolerate electrical stimulation; Lower motor neuron injury or peripheral nerve injury in the legs that would prevent the muscles from responding to electrical stimulation
  • SCI T12 and below (or lacking upper motorneuron injury)
  • Complete paraplegia or tetraplegia (classified as AIS A)
  • AIS B incomplete paraplegia or tetraplegia
  • Unable to give informed consent to participate in the study
  • Weight over 160 kg (352 lbs)
  • Pregnancy
  • Prisoners

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Spinal cord injury

Where in United States

  • Shirley Ryan AbilityLabChicago, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

The purpose of this study is to examine interventions with paradigms involving upper and lower extremity cycling (A\&L cycling) with A\&L cycling with functional electrical stimulation (FES) (A\&L_FES group), A\&L cycling with FES and transcutaneous Spinal Cord Stimulation (A\&L_tSCS group), and control Body Weight Supported Treadmill Training (BWSTT) to potentially restore functional abilities (i.e., walking) in individuals with an incomplete spinal cord injury. The researchers hypothesize there will be improved walking function following these interventional groups.

The 3 groups in the trial

  • A&L_tSCS groupTreatment being tested

    This paradigm combines A\&L\_FES with transcutaneous spinal cord stimulation (tSCS)applied with cathodic electrodes at the C3-C4 and C6-C7 spinous processes and anodic electrodes at the iliac crests. The stimulation intensity is set to trigger a spinal evoked potential, ensuring a strong but tolerable sensation at the cathode sites without evoking direct motor responses in the arm or leg EMG.

    Treatment: A&L cycling

  • A&L_FES groupSham treatment, for comparison

    This paradigm uses a commercially available motorized ergometer that link the arms \& legs mechanically to support voluntary arm and leg cycling and provide reciprocal movements that resemble those during walking. FES is used to assist the the voluntary leg movements, which also enhances proprioceptive feedback. Specifically, functional electrical stimulation (FES) is applied to the major muscles of both legs-including the quadriceps, hamstrings, and gluteus maximus-using pairs of surface electrodes. For sham transcutaneous spinal cord stimulation (tSCS), electrodes will be placed but no tSCS current will be delivered.

    Treatment: A&L cycling

  • BWSTT groupExisting treatment, for comparison

    This is the control intervention. Participants will first be assisted by physical therapists/trainers to wear any necessary lower extremity braces along with a padded walking harness. They will then be helped onto the treadmill, either from a wheelchair via a ramp or by walking with physical assistance. Once on the treadmill, they will be clipped into the body weight support system, assisted to a standing position, and provided with the appropriate level of body weight support to facilitate successful stepping.

    Treatment: Body weight supported treadmill training (BWSTT)

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Stimulation-assisted Arm and Leg Cycling for Accelerated Recovery From Spinal Cord Injury
Plain-language title
Arm and leg cycling with stimulation for people with spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06873776, who can take part
Record updated
23 May 2025